AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
LEVITT,HARRY,NAFTALI - OBITUARY
Authors: LEVITT D
Citation: D. Levitt, LEVITT,HARRY,NAFTALI - OBITUARY, BMJ. British medical journal, 317(7159), 1998, pp. 685-686
TRIBUTE TO A GOLDEN STANDARD BEARER
Authors: LEVITT D
Citation: D. Levitt, TRIBUTE TO A GOLDEN STANDARD BEARER, IEEE software, 15(6), 1998, pp. 6-6
RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND-STUDY OF A CMV GLYCOPROTEIN H-SPECIFIC MONOCLONAL-ANTIBODY (MSL-109) FOR PREVENTION OF CMV INFECTION AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANT (HSCT)
Authors: BOECKH M BOWDEN RA CHAO NJ STORER B SPIELBERGER R TIERNEY DK HAWKINS G CUNNINGHAM T LEVITT D ZAIA JA
Citation: M. Boeckh et al., RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND-STUDY OF A CMV GLYCOPROTEIN H-SPECIFIC MONOCLONAL-ANTIBODY (MSL-109) FOR PREVENTION OF CMV INFECTION AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANT (HSCT), Bone marrow transplantation, 21, 1998, pp. 477-477
THE HOMO-DIMERIC FORM OF ADP-RIBOSYL CYCLASE IN SOLUTION
Authors: MUNSHI C BAUMANN C LEVITT D BLOOMFIELD VA LEE HC
Citation: C. Munshi et al., THE HOMO-DIMERIC FORM OF ADP-RIBOSYL CYCLASE IN SOLUTION, Biochimica et biophysica acta. Protein structure and molecular enzymology, 1388(2), 1998, pp. 428-436
COMPARTMENTAL INVOLVEMENT IN KNEE OSTEOARTHRITIS AND RELATIONSHIP TO PATIENT OUTCOMES
Authors: VOGT MT STARZ T IRRGANG J LEVITT D
Citation: Mt. Vogt et al., COMPARTMENTAL INVOLVEMENT IN KNEE OSTEOARTHRITIS AND RELATIONSHIP TO PATIENT OUTCOMES, Arthritis and rheumatism, 41(9), 1998, pp. 264-264
INTEGRATION AND APPLICATION OF DISEASE STATE AND PRIMARY-CARE CASE-MANAGEMENT PRINCIPLES IN A PRIMARY-CARE SETTING UTILIZING OSTEOARTHRITISOF THE KNEE MODEL IN AN ACADEMIC-MEDICAL-CENTER
Authors: LEVITT D VERNER C DYE L STARZ T VOGT M IRRGANG J
Citation: D. Levitt et al., INTEGRATION AND APPLICATION OF DISEASE STATE AND PRIMARY-CARE CASE-MANAGEMENT PRINCIPLES IN A PRIMARY-CARE SETTING UTILIZING OSTEOARTHRITISOF THE KNEE MODEL IN AN ACADEMIC-MEDICAL-CENTER, Arthritis and rheumatism, 41(9), 1998, pp. 1555-1555
TELOMERASE ACTIVITY AND SURVIVAL OF PATIENTS WITH NODE-POSITIVE BREAST-CANCER
Authors: CLARK GM OSBORNE CK LEVITT D WU F KIM NW
Citation: Gm. Clark et al., TELOMERASE ACTIVITY AND SURVIVAL OF PATIENTS WITH NODE-POSITIVE BREAST-CANCER, Journal of the National Cancer Institute, 89(24), 1997, pp. 1874-1881
CONCURRENT PHASE-I TRIALS OF INTRAVENOUS INTERLEUKIN-6 IN SOLID TUMORPATIENTS - REVERSIBLE DOSE-LIMITING NEUROLOGICAL TOXICITY
Authors: SOSMAN JA ARONSON FR SZNOL M ATKINS MB DUTCHER JP WEISS GR ISAACS RE MARGOLIN KA FISHER RI ERNEST ML MIER J OLEKSOWICZ L ECKHARDT JR LEVITT D DOROSHOW JH
Citation: Ja. Sosman et al., CONCURRENT PHASE-I TRIALS OF INTRAVENOUS INTERLEUKIN-6 IN SOLID TUMORPATIENTS - REVERSIBLE DOSE-LIMITING NEUROLOGICAL TOXICITY, Clinical cancer research, 3(1), 1997, pp. 39-46
VALIDITY OF THE KNEE OUTCOME SURVEY IN PATIENTS WITH OSTEOARTHRITIS OF THE KNEE
Authors: THACHUK C IRRGANG J STARZ T LEVITT D
Citation: C. Thachuk et al., VALIDITY OF THE KNEE OUTCOME SURVEY IN PATIENTS WITH OSTEOARTHRITIS OF THE KNEE, Arthritis and rheumatism, 40(9), 1997, pp. 862-862
ACTING ON A LIVING WILL - A PHYSICIANS DILEMMA
Authors: GORDON M LEVITT D
Citation: M. Gordon et D. Levitt, ACTING ON A LIVING WILL - A PHYSICIANS DILEMMA, CMAJ. Canadian Medical Association journal, 155(7), 1996, pp. 893-895
COMPARISON OF 4 CYTOKINE REGIMENS FOR MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS - IL-3 ALONE AND COMBINED WITH GM-CSF OR G-CSF
Authors: ROSENFELD CS BOLWELL B LEFEVER A TAYLOR R LIST A FAY J COLLINS R ANDREWS F PALLANSCH P SCHUSTER MW RESTA D LEVITT D NEMUNAITIS J
Citation: Cs. Rosenfeld et al., COMPARISON OF 4 CYTOKINE REGIMENS FOR MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS - IL-3 ALONE AND COMBINED WITH GM-CSF OR G-CSF, Bone marrow transplantation, 17(2), 1996, pp. 179-183
CREATING A LIVING WILL - EXPERIENCE AT A MULTILEVEL GERIATRIC FACILITY
Authors: LEVITT D GORDON M
Citation: D. Levitt et M. Gordon, CREATING A LIVING WILL - EXPERIENCE AT A MULTILEVEL GERIATRIC FACILITY, Canadian family physician, 42, 1996, pp. 2413
PHYSICIANS, ETHICS, ADVANCE DIRECTIVES, AND LONG-TERM-CARE
Authors: GORDON M LEVITT D
Citation: M. Gordon et D. Levitt, PHYSICIANS, ETHICS, ADVANCE DIRECTIVES, AND LONG-TERM-CARE, Journal of the American Geriatrics Society, 44(4), 1996, pp. 471-472
PHASE-I TRIAL OF RECOMBINANT INTERLEUKIN-3 BEFORE AND AFTER CARBOPLATIN ETOPOSIDE CHEMOTHERAPY IN PATIENTS WITH SOLID TUMORS - A SOUTHWEST-ONCOLOGY-GROUP STUDY
Authors: RINEHART J MARGOLIN KA TRIOZZI P HERSH E CAMPION M RESTA D LEVITT D
Citation: J. Rinehart et al., PHASE-I TRIAL OF RECOMBINANT INTERLEUKIN-3 BEFORE AND AFTER CARBOPLATIN ETOPOSIDE CHEMOTHERAPY IN PATIENTS WITH SOLID TUMORS - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Clinical cancer research, 1(10), 1995, pp. 1139-1144
THE CRYSTAL-STRUCTURE OF FUMARASE-C FROM ESCHERICHIA-COLI
Authors: WEAVER T LEVITT D BANASZAK L DONNELLY M WILKENSSTEVENS P
Citation: T. Weaver et al., THE CRYSTAL-STRUCTURE OF FUMARASE-C FROM ESCHERICHIA-COLI, The FASEB journal, 9(6), 1995, pp. 1466-1466
DYNAMIC GEOMETRY OF NORMAL MITRAL ANNULUS AND PAPILLARY-MUSCLES
Authors: KOMEDA M GLASSON JR BOLGER AF LEVITT D DAUGHTERS GT NICZYPORUK MA INGELS NB MILLER DC
Citation: M. Komeda et al., DYNAMIC GEOMETRY OF NORMAL MITRAL ANNULUS AND PAPILLARY-MUSCLES, Circulation, 92(8), 1995, pp. 2456-2456
THE CRYSTAL-STRUCTURE OF CYCLIC ADP-RIBOSE
Authors: LEE HC AARHUS R LEVITT D
Citation: Hc. Lee et al., THE CRYSTAL-STRUCTURE OF CYCLIC ADP-RIBOSE, Nature structural biology, 1(3), 1994, pp. 143-144
A PHASE-I TRIAL OF INTRAVENOUS INTERLEUKIN-6 IN PATIENTS WITH ADVANCED CANCER
Authors: WEBER J GUNN H YANG J PARKINSON D TOPALIAN S SCHWARTZENTRUBER D ETTINGHAUSEN S LEVITT D ROSENBERG SA
Citation: J. Weber et al., A PHASE-I TRIAL OF INTRAVENOUS INTERLEUKIN-6 IN PATIENTS WITH ADVANCED CANCER, Journal of immunotherapy with emphasis on tumor immunology, 15(4), 1994, pp. 292-302
EFFECT OF RECOMBINANT HUMAN INTERLEUKIN-3 ON HEMATOLOGICAL RECOVERY FROM CHEMOTHERAPY-INDUCED MYELOSUPPRESSION
Authors: TEPLER I ELIAS A KALISH L SHULMAN L STRAUSS G SKARIN A LYNCH T LEVITT D RESTA D DEMETRI G GAYNES L SCHNIPPER L
Citation: I. Tepler et al., EFFECT OF RECOMBINANT HUMAN INTERLEUKIN-3 ON HEMATOLOGICAL RECOVERY FROM CHEMOTHERAPY-INDUCED MYELOSUPPRESSION, British Journal of Haematology, 87(4), 1994, pp. 678-686
A PHASE-II TRIAL OF G-CSF WITH OR WITHOUT SDZ ILE-964 (IL-3) FOR THE MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) FOR AUTOLOGOUS PROGENITOR-CELL TRANSPLANTATION
Authors: BOLWELL B ROSENFELD C LEFEVER A LIST A ANDREWS F SCHUSTER M LEVITT D RESTA D GEORGE M NEMUNAITIS J COLLINS R
Citation: B. Bolwell et al., A PHASE-II TRIAL OF G-CSF WITH OR WITHOUT SDZ ILE-964 (IL-3) FOR THE MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) FOR AUTOLOGOUS PROGENITOR-CELL TRANSPLANTATION, Blood, 84(10), 1994, pp. 10000106-10000106
PHARMACOKINETICS AND PHARMACODYNAMICS OF RECOMBINANT INTERLEUKIN-3 (RHIL-3) FOLLOWING SUBCUTANEOUS (SQ) ADMINISTRATION TO PATIENTS WITH REFRACTORY MALIGNANCIES
Authors: BUKOWSKI RM OLENCKI T MCLAIN D TUASON L BUDD GT SANDSTROM K RAYMAN P GUNN H LEVITT D FINKE J
Citation: Rm. Bukowski et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF RECOMBINANT INTERLEUKIN-3 (RHIL-3) FOLLOWING SUBCUTANEOUS (SQ) ADMINISTRATION TO PATIENTS WITH REFRACTORY MALIGNANCIES, Blood, 84(10), 1994, pp. 10000580-10000580
HEMATOLOGIC EFFECTS OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RHUGM-CSF) AND INTERLEUKIN-6 (RHIL-6) ADMINISTERED TO PATIENTS WITH MALIGNANCY
Authors: WOS E OLENCKI T BUDD GT PEEREBOOM D FINKE J WOOD L MCLAIN D TUBBS R REDOVAN C EDINGER M LEVITT D BUKOWSKI RM
Citation: E. Wos et al., HEMATOLOGIC EFFECTS OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RHUGM-CSF) AND INTERLEUKIN-6 (RHIL-6) ADMINISTERED TO PATIENTS WITH MALIGNANCY, Blood, 84(10), 1994, pp. 10000598-10000598
IMMUNOMODULATORY EFFECTS OF RECOMBINANT INTERLEUKIN-3 TREATMENT ON HUMAN ALVEOLAR MACROPHAGES AND MONOCYTES
Authors: THOMASSEN MJ ANTAL JM CONNORS MJ MCLAIN D SANDSTROM K MEEKER DP BUDD GT LEVITT D BUKOWSKI RM
Citation: Mj. Thomassen et al., IMMUNOMODULATORY EFFECTS OF RECOMBINANT INTERLEUKIN-3 TREATMENT ON HUMAN ALVEOLAR MACROPHAGES AND MONOCYTES, Journal of immunotherapy with emphasis on tumor immunology, 14(1), 1993, pp. 43-50
MUTATION SCREENING OF COMPLETE FIBRILLIN-1 CODING SEQUENCE - REPORT OF 5 NEW MUTATIONS, INCLUDING 2 IN 8-CYSTEINE DOMAINS
Authors: TYNAN K COMEAU K PEARSON M WILGENBUS P LEVITT D GASNER C BERG MA MILLER DC FRANCKE U
Citation: K. Tynan et al., MUTATION SCREENING OF COMPLETE FIBRILLIN-1 CODING SEQUENCE - REPORT OF 5 NEW MUTATIONS, INCLUDING 2 IN 8-CYSTEINE DOMAINS, Human molecular genetics, 2(11), 1993, pp. 1813-1821
PHASE-I TRIAL WITH RECOMBINANT HUMAN INTERLEUKIN-3 IN PATIENTS WITH LYMPHOMA UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANTATION
Authors: NEMUNAITIS J APPELBAUM FR SINGER JW LILLEBY K WOLFF S GREER JP BIERMAN P RESTA D CAMPION M LEVITT D ZEIGLER Z ROSENFELD C SHADDUCK RK BUCKNER CD
Citation: J. Nemunaitis et al., PHASE-I TRIAL WITH RECOMBINANT HUMAN INTERLEUKIN-3 IN PATIENTS WITH LYMPHOMA UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Blood, 82(11), 1993, pp. 3273-3278
Risultati: 1-25 | 26-29